Celcuity ( (CELC) ) is experiencing volatility. Read on for a possible explanation for the stock’s unusual movement.
Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Celcuity Inc. is tumbling after it announced a new public stock offering that will dilute existing shareholders. The offering was priced well below the prior closing share price, pressuring the stock as investors reassess the company’s valuation.
The sell-off also appears to be fueled by profit-taking, coming on the heels of a strong multi-day rally and solid year-to-date gains. Analysts note that this type of discounted fundraising is common for clinical-stage biotech firms financing key drug candidates like gedatolisib.
More about Celcuity
YTD Price Performance: 24.96%
Average Trading Volume: 730,217
Technical Sentiment Signal: Buy
Current Market Cap: $6.02B
For further insights into CELC stock on TipRanks’ Stock Analysis page.
See more of today’s top stock gainers and losers.